Patents by Inventor Jaroslav Kyncl

Jaroslav Kyncl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4166819
    Abstract: This invention provides 4-aroyl substituted phenoxy acetic acids and tetrazoles of the formula ##STR1## wherein R is a phenyl ring, a substituted phenyl ring, or naphthyl; R.sub.1 is --CH.sub.2 COOH or methyl tetrazole, and X.sub.1 and X.sub.2 are each a halogen or loweralkyl, or when taken together form with the two attached carbons a phenyl ring.These compounds are useful as antihypertensive agents, diuretics and uricosuric agents.
    Type: Grant
    Filed: September 6, 1977
    Date of Patent: September 4, 1979
    Assignee: Abbott Laboratories
    Inventors: Peter H. Jones, Dilbagh S. Bariana, Anthony K. L. Fung, Yvonne C. Martin, Jaroslav Kyncl, Amrit Lall
  • Patent number: 4112097
    Abstract: Described are antihypertensive agents selected from the class consisting of 2[4(tetrahydro-2-furoyl)-piperazino]-4-amino-6,7-dimethoxyquinazoline and 2-[4(tetrahydropyran-2-carbonyl)-piperazinyl]-4-amino-6,7-dimethoxyquinazo line, and pharmaceutically acceptable acid addition salts thereof. The compounds are highly water soluble and can be administered in time release form as well as parenterally, including intravenously.
    Type: Grant
    Filed: January 21, 1977
    Date of Patent: September 5, 1978
    Assignee: Abbott Laboratories
    Inventors: Martin Winn, Jaroslav Kyncl, Daniel Ambrose Dunnigan, Peter Hadley Jones
  • Patent number: 4105788
    Abstract: This invention covers diacylated derivatives of .gamma.-glutamyl dopamine selected from the group consisting of ##STR1## where R is a C.sub.1 -C.sub.12 straight or branched chain alkyl radical, a phenyl ring or a substituted phenyl ring and R' is H or a C.sub.1 -C.sub.7 alkyl, and a pharmaceutically acceptable acid addition salt thereof.The compounds of this invention are useful to increase the renal blood flow by being administered to warm-blooded animals by clinically accepted routes of administration such as oral, parenteral, rectal and the like.
    Type: Grant
    Filed: May 3, 1977
    Date of Patent: August 8, 1978
    Assignee: Abbott Laboratories
    Inventors: Peter H. Jones, Carroll W. Curs, Jaroslav Kyncl
  • Patent number: 4105787
    Abstract: This invention covers diacylated derivatives of .gamma.-glutamyl dopamine selected from the group consisting of ##STR1## where R is a C.sub.1 -C.sub.12 straight or branched chain alkyl radical, a phenyl ring or a substituted phenyl ring and R' is H or a C.sub.1 -C.sub.7 alkyl, and a pharmaceutically acceptable acid addition salt thereof.The compounds of this invention are useful to increase the renal blood flow by being administered to warm-blooded animals by clinically accepted routes of administration such as oral, parenteral, rectal and the like.
    Type: Grant
    Filed: May 3, 1977
    Date of Patent: August 8, 1978
    Assignee: Abbott Laboratories
    Inventors: Peter H. Jones, Carroll W. Curs, Jaroslav Kyncl
  • Patent number: 4093726
    Abstract: Disclosed are compounds of the formula ##STR1## wherein n is 2 or 3, R is hydrogen or methyl, R' is C.sub.1 -C.sub.6 alkyl, acyl, aryl, aroyl, alkoxycarbonyl, tetrahydrofuroyl, dialkylaminocarbonyl, or furoyl, and R" is hydrogen and methoxy. These compounds are useful as antihypertensive agents.
    Type: Grant
    Filed: December 2, 1976
    Date of Patent: June 6, 1978
    Assignee: Abbott Laboratories
    Inventors: Martin Winn, Jaroslav Kyncl
  • Patent number: 4088765
    Abstract: Described are the compounds 5,6-dimethoxy-2-(4-benzyl-1-piperidino) benzimidazole and 5,6-dimethoxy-2 (6,7-dimethoxy-1,2,3,4-tetrahydro 2-isoquinolinyl benzimidazole and pharmaceutically acceptable acid addition salts thereof. The compounds are useful as antihypertensive agents.
    Type: Grant
    Filed: December 2, 1976
    Date of Patent: May 9, 1978
    Assignee: Abbott Laboratories
    Inventors: Martin Winn, Jaroslav Kyncl
  • Patent number: 4058559
    Abstract: This invention provides 4-aroyl substituted phenoxy acetic acids and tetrazoles of the formula ##STR1## wherein R is a phenyl ring, a substituted phenyl ring, or naphthyl; R.sub.1 is --CH.sub.2 COOH or methyl tetrazole, and X.sub.1 and X.sub.2 are each a halogen or loweralkyl, or when taken together form with the two attached carbons a phenyl ring.These compounds are useful as antihypertensive agents, diuretics and uricosuric agents.
    Type: Grant
    Filed: September 24, 1975
    Date of Patent: November 15, 1977
    Assignee: Abbott Laboratories
    Inventors: Peter Hadley Jones, Dilbagh Singh Bariana, Anthony Kei Lun Fung, Yvonne Connolly Martin, Jaroslav Kyncl, Amrit Lall
  • Patent number: 4044135
    Abstract: Described are the compounds 2[4(tetrahydro-2-furoyl)-hexahydro-1,4-diazepinyl-1]-4-amino-6,7-dimethoxy quinazoline and pharmaceutically acceptable acid addition salts thereof. The compounds are useful as antihypertensive agents.
    Type: Grant
    Filed: October 14, 1975
    Date of Patent: August 23, 1977
    Assignee: Abbott Laboratories
    Inventors: Martin Winn, Jaroslav Kyncl, Daniel Ambrose Dunnigan, Peter Handley Jones
  • Patent number: 4031242
    Abstract: This invention covers diacylated derivatives of .gamma.-glutamyl dopamine selected from the group consisting of ##STR1## where R is a C.sub.1 -C.sub.12 straight or branched chain alkyl radical, a phenyl ring or a substituted phenyl ring and R' is H or a C.sub.1 -C.sub.7 alkyl, and a pharmaceutically acceptable acid addition salt thereof.The compounds of this invention are useful to increase the renal blood flow by being administered to warm-blooded animals by clinically accepted routes of administration such as oral, parenteral, rectal and the like.
    Type: Grant
    Filed: September 11, 1975
    Date of Patent: June 21, 1977
    Assignee: Abbott Laboratories
    Inventors: Peter Hadley Jones, Carroll Wayne Ours, Jaroslav Kyncl
  • Patent number: 4026894
    Abstract: Described are antihypertensive agents selected from the class consisting of 2[4(tetrahydro-2-furoyl)-piperazino]-4-amino-6,7-dimethoxyquinazoline and 2-[4(tetrahydropyran-2-carbonyl)-piperazinyl]-4-amino-6,7-dimethoxyquinazo line, and pharmaceutically acceptable acid addition salts thereof. The compounds are highly water soluble and can be administered in time release form as well as parenterally, including intravenously.
    Type: Grant
    Filed: October 14, 1975
    Date of Patent: May 31, 1977
    Assignee: Abbott Laboratories
    Inventors: Martin Winn, Jaroslav Kyncl, Daniel Ambrose Dunnigan, Peter Hadley Jones
  • Patent number: 4017636
    Abstract: Covers the esters of .gamma.-glutamyl amide of dopamine selected from the group consisting of ##STR1## where R is a C.sub.1 -C.sub.18 alkyl radical, and a pharmaceutically acceptable acid addition salt thereof. Also covers the use of said esters of .gamma.-glutamyl amide of dopamine to increase renal blood flow by administering said amide to warm-blooded mammals by clinically acceptable routes of administration such as oral, parenteral, rectal, etc.
    Type: Grant
    Filed: September 24, 1975
    Date of Patent: April 12, 1977
    Assignee: Abbott Laboratories
    Inventors: Peter Hadley Jones, Jaroslav Kyncl, Carroll Wayne Ours, Pitambar Somani
  • Patent number: 3947590
    Abstract: Covers a .gamma.-glutamyl amide of dopamine selected from the group consisting of ##EQU1## and a pharmaceutically acceptable acid addition salt thereof. Also covers the use of said .gamma.-glutamyl amide to increase renal blood flow by administering said amide to warm-blooded mammals.
    Type: Grant
    Filed: January 27, 1975
    Date of Patent: March 30, 1976
    Assignee: Abbott Laboratories
    Inventors: Jaroslav Kyncl, Kathleen Riley Lynn, Yvonne Connolly Martin, Carroll Wayne Ours